Detalhe da pesquisa
1.
EULAR recommendations for the involvement of patient research partners in rheumatology research: 2023 update.
Ann Rheum Dis;
2024 Jun 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38876509
2.
Effectiveness of Sequential Lines of Biologic and Targeted Small Molecule Drugs in Psoriatic Arthritis: A Systematic Review.
Rheumatology (Oxford);
2024 Jan 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38243715
3.
The comparative performance of three screening questionnaires for psoriatic arthritis in a primary care surveillance study.
Rheumatology (Oxford);
63(4): 991-998, 2024 Apr 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37341637
4.
Enhancing current guidance for psoriatic arthritis and its comorbidities: recommendations from an expert consensus panel.
Rheumatology (Oxford);
2024 Mar 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38490262
5.
Effect of bimekizumab on symptoms and impact of disease in patients with psoriatic arthritis over 3 years: results from BE ACTIVE.
Rheumatology (Oxford);
62(2): 617-628, 2023 02 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35789257
6.
Upadacitinib in patients with psoriatic arthritis and inadequate response to biologics: 3-year results from the open-label extension of the randomised controlled phase 3 SELECT-PsA 2 study.
Clin Exp Rheumatol;
41(11): 2286-2297, 2023 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37404160
7.
Using Bayesian networks to identify musculoskeletal symptoms influencing the risk of developing psoriatic arthritis in people with psoriasis.
Rheumatology (Oxford);
61(2): 581-590, 2022 02 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33769484
8.
Upadacitinib for psoriatic arthritis refractory to biologics: SELECT-PsA 2.
Ann Rheum Dis;
80(3): 312-320, 2021 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33272960
9.
Treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scope.
Rheumatology (Oxford);
60(4): 1588-1592, 2021 04 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33097948
10.
Composite Measures for Clinical Trials in Psoriatic Arthritis: Testing Pain and Fatigue Modifications in a UK Multicenter Study.
J Rheumatol Suppl;
97: 39-44, 2021 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34074665
11.
Composite Measures for Routine Clinical Practice in Psoriatic Arthritis: Testing of Shortened Versions in a UK Multicenter Study.
J Rheumatol Suppl;
97: 45-49, 2021 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34074666
12.
Instruments Measuring Physical Function for Psoriatic Arthritis Endorsed at GRAPPA 2020 Annual Meeting: Updates of the GRAPPA-OMERACT Working Group.
J Rheumatol Suppl;
97: 60-63, 2021 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34074670
13.
Effect of filgotinib on health-related quality of life in active psoriatic arthritis: a randomized phase 2 trial (EQUATOR).
Rheumatology (Oxford);
59(7): 1495-1504, 2020 07 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31624837
14.
Clinically meaningful improvement in work productivity loss in active psoriatic arthritis: post-hoc analysis of SPIRIT-P1 and SPIRIT-P2 trials.
Clin Exp Rheumatol;
38(6): 1227-1230, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32452352
15.
Outcomes of the 2019 GRAPPA Workshop on Continuous Composite Indices for the Assessment of Psoriatic Arthritis and Membership-recommended Next Steps.
J Rheumatol Suppl;
96: 11-18, 2020 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32482762
16.
The GRAPPA-OMERACT Working Group: 4 Prioritized Domains for Completing the Core Outcome Measurement Set for Psoriatic Arthritis 2019 Updates.
J Rheumatol Suppl;
96: 46-49, 2020 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32482768
17.
Trajectory of radiographic change over a decade: the effect of transition from conventional synthetic disease-modifying antirheumatic drugs to anti-tumour necrosis factor in patients with psoriatic arthritis.
Rheumatology (Oxford);
58(2): 269-273, 2019 02 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30247726
18.
Risk of type 2 diabetes and cardiovascular disease in an incident cohort of people with psoriatic arthritis: a population-based cohort study.
Rheumatology (Oxford);
58(1): 144-148, 2019 01 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30202906
19.
The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set.
J Rheumatol Suppl;
95: 33-37, 2019 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31154402
20.
Validation of the Psoriatic Arthritis Impact of Disease (PsAID) Questionnaire and its potential as a single-item outcome measure in clinical practice.
Ann Rheum Dis;
77(3): 343-347, 2018 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29146740